Abstract:
Novel high resolution methods and precipitating reagents for isolating desired protein populations from proteinaceous materials are disclosed. Uniquely, the methods and precipitating reagents of this invention are suitable for selectively and sequentially isolating consistently in high yields desired protein populations from various proteinaceous materials based upon the physical and chemical characteristics inherent in, and/or peculiar to, the desired protein populations. In addition, desired protein populations isolated with the new and vastly improved methods and precipitating reagents of this invention are highly concentrated and substantially pure and biologically active. The precipitating reagents basically are an alkali metal salt of a polyfunctional organic acid, exemplified by tri-potassium citrate monohydrate or tri-sodium citrate dihydrate, and a buffer for adjusting pH. Sources of proteinaceous materials may include, for example, animal or vegetable fluids and extracts.
Abstract:
The present invention is a mixture for treating and preventing periodontal disease comprising acemannan, an immuno-stimulant with tissue repair activity and a hydrated dialkali monometai polycarboxylate 1 : 1 molar ratio of metal-to-complexing agent, such that lysyl oxidase for collagen formation and subsequent tissue repair is activated.
Abstract:
The present invention is a synergistic palliative and/or therapeutic admixture for treating and/or medicating affected biological tissue in mammals. The admixture includes two or more multivalent metals and at least one polyfunctional organic ligand. The ligand is in the form of an alkaline earth salt. The molar ratio of metal to ligand is 1:1.
Abstract:
The present invention is a mixture for treating and preventing periodontal disease comprising acemannan, an immuno-stimulant with tissue repair activity and a hydrated dialkali monometai polycarboxylate 1 : 1 molar ratio of metal-to-complexing agent, such that lysyl oxidase for collagen formation and subsequent tissue repair is activated.
Abstract:
A method of reducing odor from ostomy devices by using a hydrated dialkali monometal polycarboxylate 1 :1 molar ratio of metal-to-complexing agent suspended in a carrier. As the ostomy device is filled with waste products, the hydrated dialkali monometal polycarboxylate 1 : 1 molar ratio of metal-to-complexing agent oxidizes the molecules of the waste products and neutralizes odor-causing molecules, and thereby reduces associated odors.
Abstract:
The present invention is a palliative or therapeutic foam for medicating or treating affected biological tissue having a pH of 7.0 to 8.0 and including a hydrated dialkali monometal complex such as disodium monocopper(II) citrate dihydrate,or disodium monozinc(II) citrate dihydrate and triethanolamine lauryl sulfate in a concentration of less than 10%.
Abstract:
The present invention is a palliative or therapeutic foam for medicating or treating affected biological tissue having a pH of 7.0 to 8.0 and including a hydrated dialkali monometal complex such as disodium monocopper(II) citrate dihydrate or disodium monozinc(II) citrate dihydrate and triethanolamine lauryl sulfate in a concentration of less than 10%.
Abstract:
A method of reducing odor from ostomy devices by using a hydrated dialkali monometal polycarboxylate 1 :1 molar ratio of metal-to-complexing agent suspended in a carrier. As the ostomy device is filled with waste products, the hydrated dialkali monometal polycarboxylate 1 : 1 molar ratio of metal-t o- complexing agent oxidizes the molecules of the waste products and neutralize s odor-causing molecules, and thereby reduces associated odors.